Comparision between of Ropivacaine and Lidocain with Epinephrin in patient undergoing cleft palate repair

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210515051299N1

Enrollment

Registered

2021-05-24

Start date

2021-06-22

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cleft palate. Cleft palate

Interventions

Intervention 1: Intervention group1: lidocaine 2 mg per kilogram of body weight with epinephrine 1/80000 is injected locally at the incision site by the surgical service. Intervention 2: Intervention

Eligibility

Sex/Gender

All

Age

6 Months to 2 Years

Inclusion criteria

Inclusion criteria: Candidate for cleft palate surgery

Exclusion criteria

Exclusion criteria: Allergy to local anesthetics,and bleeding disorders Bleeding disorders Cardiovascolar disorders Brain disorders

Design outcomes

Primary

Measure	Time frame
Complications of anesthesia, including heart rate, blood pressure and anesthesia. Timepoint: During anesthesia. Method of measurement: check of vital sign.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEghbali Ahmad

Shahid Beheshti University of Medical Sciences

eghbali@yahoo.com+98 21 3333 0006

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026